ZIMMER BIOMET HOLDINGS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$888.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2025-02-25
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2023-12-31 was -$220.80M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2023-09-30 was -$165.60M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2023-06-30 was -$243.10M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2023-03-31 was -$149.40M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2024 was -$888.10M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2023 was -$778.90M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2022 was -$522.00M.
- ZIMMER BIOMET HOLDINGS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2020 was -$564.30M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | -$888.10M 10-K · filed 2025-02-25 | ||||
| 2023-12-31 | -$220.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$386.40M derived: sum of 2 quarters · filed 2025-02-25 | -$629.50M derived: sum of 3 quarters · filed 2025-02-25 | -$778.90M 10-K · filed 2025-02-25 | |
| 2023-09-30 | -$165.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$408.70M derived: sum of 2 quarters · filed 2023-11-07 | -$558.10M 10-Q · filed 2023-11-07 | -$670.60M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | -$243.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$392.50M 10-Q · filed 2023-08-01 | -$505.00M derived: sum of 3 quarters · filed 2025-02-25 | -$590.20M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | -$149.40M 10-Q · filed 2023-05-02 | -$261.90M derived: sum of 2 quarters · filed 2025-02-25 | -$347.10M derived: sum of 3 quarters · filed 2025-02-25 | -$590.30M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | -$112.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$197.70M derived: sum of 2 quarters · filed 2025-02-25 | -$440.90M derived: sum of 3 quarters · filed 2025-02-25 | -$522.00M 10-K · filed 2025-02-25 | |
| 2022-09-30 | -$85.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$328.40M derived: sum of 2 quarters · filed 2023-11-07 | -$409.50M 10-Q · filed 2023-11-07 | -$533.50M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2022-06-30 | -$243.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$324.30M 10-Q · filed 2023-08-01 | -$448.30M derived: sum of 3 quarters · filed 2024-08-07 | -$560.60M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2022-03-31 | -$81.10M 10-Q · filed 2023-05-02 | -$205.10M derived: sum of 2 quarters · filed 2024-08-07 | -$317.40M derived: sum of 3 quarters · filed 2024-08-07 | -$416.30M derived: sum of 4 quarters · filed 2024-08-07 | |
| 2021-12-31 | -$124.00M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | -$236.30M derived: sum of 2 quarters · filed 2024-08-07 | -$335.20M derived: sum of 3 quarters · filed 2024-08-07 | -$443.30M 8-K · filed 2024-08-07 | |
| 2021-09-30 | -$112.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$211.20M derived: sum of 2 quarters · filed 2022-11-02 | -$319.30M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | -$98.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$207.00M 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | -$108.10M 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | -$564.30M 10-K · filed 2023-02-24 | ||||
| 2019-12-31 | -$644.70M 8-K · filed 2022-06-22 | ||||
| 2018-03-31 | -$101.70M 10-Q · filed 2018-05-08 | -$229.90M derived: sum of 2 quarters · filed 2018-05-08 | -$350.40M derived: sum of 3 quarters · filed 2018-05-08 | -$479.40M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-12-31 | -$128.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$248.70M derived: sum of 2 quarters · filed 2018-02-27 | -$377.70M derived: sum of 3 quarters · filed 2018-02-27 | -$510.80M 10-K · filed 2018-02-27 | |
| 2017-09-30 | -$120.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$249.50M derived: sum of 2 quarters · filed 2017-11-06 | -$382.60M 10-Q · filed 2017-11-06 | -$529.40M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-06-30 | -$129.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$262.10M 10-Q · filed 2017-08-08 | -$408.90M derived: sum of 3 quarters · filed 2018-05-08 | -$1.78B derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-03-31 | -$133.10M 10-Q · filed 2018-05-08 | -$279.90M derived: sum of 2 quarters · filed 2018-05-08 | -$1.65B derived: sum of 3 quarters · filed 2018-05-08 | -$1.92B derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | -$146.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.52B derived: sum of 2 quarters · filed 2018-02-27 | -$1.79B derived: sum of 3 quarters · filed 2018-02-27 | -$1.69B 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$1.37B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$1.64B derived: sum of 2 quarters · filed 2017-11-06 | -$1.54B 10-Q · filed 2017-11-06 | -$1.48B derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | -$266.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$170.40M 10-Q · filed 2017-08-08 | -$101.70M derived: sum of 3 quarters · filed 2018-02-27 | -$7.60M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $95.80M 10-Q · filed 2017-05-09 | $164.50M derived: sum of 2 quarters · filed 2018-02-27 | $258.60M derived: sum of 3 quarters · filed 2018-02-27 | -$7.53B derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | $68.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $162.80M derived: sum of 2 quarters · filed 2018-02-27 | -$7.63B derived: sum of 3 quarters · filed 2018-02-27 | -$7.56B 10-K · filed 2018-02-27 | |
| 2015-09-30 | $94.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$7.69B derived: sum of 2 quarters · filed 2016-11-08 | -$7.63B 10-Q · filed 2016-11-08 | -$7.68B 10-Q · filed 2015-11-09 | -$7.60B derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$7.79B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$7.72B 10-Q · filed 2016-08-08 | -$7.69B derived: sum of 3 quarters · filed 2017-03-01 | -$7.92B derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $67.90M 10-Q · filed 2016-05-10 | $96.60M derived: sum of 2 quarters · filed 2017-03-01 | -$132.80M derived: sum of 3 quarters · filed 2017-03-01 | -$303.10M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $28.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$200.70M derived: sum of 2 quarters · filed 2017-03-01 | -$371.00M derived: sum of 3 quarters · filed 2017-03-01 | -$469.40M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$229.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$399.70M derived: sum of 2 quarters · filed 2015-11-09 | -$498.10M 10-Q · filed 2015-11-09 | -$508.30M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$170.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$268.70M 10-Q · filed 2015-08-10 | -$278.90M derived: sum of 3 quarters · filed 2016-02-29 | -$429.60M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$98.40M 10-Q · filed 2015-05-07 | -$108.60M derived: sum of 2 quarters · filed 2016-02-29 | -$259.30M derived: sum of 3 quarters · filed 2016-02-29 | -$433.90M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$160.90M derived: sum of 2 quarters · filed 2016-02-29 | -$335.50M derived: sum of 3 quarters · filed 2016-02-29 | -$282.50M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$150.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$325.30M derived: sum of 2 quarters · filed 2014-11-05 | -$272.30M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | -$174.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$121.60M 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $53.00M 10-Q · filed 2014-05-06 | ||||
| 2012-12-31 | -$592.10M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |